ClinConnect ClinConnect Logo
Search / Trial NCT05350904

Hybrid Telehealth in Pediatric Physical Therapy

Launched by UNIVERSITY OF MISSOURI-COLUMBIA · Apr 22, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how effective a combination of telehealth and in-person physical therapy is for children with moderate to severe disabilities compared to just in-person therapy alone. Telehealth allows children to participate in therapy sessions from home using technology, which can make it easier for families to access care. The goal is to see if this hybrid approach helps improve the everyday skills of children aged 2 to 17.

To be eligible for this study, children need to have a moderate to significant disability and their families must have the necessary technology for telehealth visits. It’s important that the child’s insurance covers these types of visits. Participants can expect to take part in both in-person and telehealth sessions, and the study is currently looking for more families to join. This research could help improve how physical therapy is delivered to children in the future!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children 2-17 years old with moderate to significant disability.
  • Families have access to minimum technology necessary to participate in a telehealth visit. ---The child's insurance covers telehealth visits.
  • Exclusion Criteria:
  • -Caregiver does not speak English

About University Of Missouri Columbia

The University of Missouri-Columbia is a leading academic institution dedicated to advancing medical research and clinical innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving patient outcomes across a variety of health conditions. With a commitment to ethical research practices and collaboration with multidisciplinary teams, the University of Missouri-Columbia strives to translate scientific discoveries into effective therapeutic interventions, ultimately enhancing the quality of care in the communities it serves.

Locations

Columbia, Missouri, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials